Used in the synthesis of boron-containing pharmaceuticals, particularly in the development of proteasome inhibitors for cancer therapy. Its structure allows for targeted interactions with enzyme active sites, making it valuable in drug design for oncology. Also employed in Suzuki-Miyaura cross-coupling reactions as an intermediate in creating biaryl compounds for medicinal chemistry research.